Influence of different media and incubation times for determining the minimum inhibitory concentrations of gepotidacin, ciprofloxacin and ceftriaxone against Neisseria gonorrhoeae
{{output}}
Gepotidacin (GSK2140944) is a novel triazaacenaphthylene antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV by a distinct binding site, a unique mechanism of action and has been approved for the treatment of urogenital gonorrhea and uncomplicat... ...
